Fibrillisation of hydrophobically modified amyloid peptide fragments in an organic solvent.

The self-assembly of a hydrophobically modified fragment of the amyloid β (Aβ) peptide has been studied in methanol. The peptide FFKLVFF is based on Aβ(16-20) extended at the N terminus by two phenylalanine residues. The formation of amyloid-type fibrils is confirmed by Congo Red staining, thioflavin T fluorescence and circular dichroism experiments. FTIR points to the formation of β-sheet structures in solution and in dried films and suggests that aggregation occurs at low concentration and is not strongly affected by further increase in concentration, i.e. the peptide is a strong fibril-former in methanol. UV fluorescence experiments on unstained peptide and CD point to the importance of aromatic interactions between phenylalanine groups in driving aggregation into β-sheets. The CD spectrum differs from that usually observed for β-sheet assemblies formed by larger peptides or proteins and this is discussed for solutions in methanol and also trifluoroethanol. The fibril structure is imaged by transmission electron microscopy and scanning electron microscopy on dried samples and is confirmed by small-angle X-ray scattering experiments in solution.

[1]  Jan Skov Pedersen,et al.  Analysis of small-angle scattering data from colloids and polymer solutions: modeling and least-squares fitting , 1997 .

[2]  L. Tjernberg,et al.  Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.

[3]  M. R. Nilsson Techniques to study amyloid fibril formation in vitro. , 2004, Methods.

[4]  J. Reed,et al.  Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. , 1992, Journal of molecular biology.

[5]  D. Teplow,et al.  Structural and kinetic features of amyloid beta-protein fibrillogenesis. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[6]  L. Serpell,et al.  Alzheimer's amyloid fibrils: structure and assembly. , 2000, Biochimica et biophysica acta.

[7]  Shan‐Yang Lin,et al.  Fourier transform infrared spectroscopy used to evidence the prevention of β-sheet formation of amyloid β(1–40) peptide by a short amyloid fragment , 2003 .

[8]  P. Lansbury,et al.  A century-old debate on protein aggregation and neurodegeneration enters the clinic , 2006, Nature.

[9]  Y. Kallberg,et al.  Prediction of Amyloid Fibril-forming Proteins* , 2001, The Journal of Biological Chemistry.

[10]  M. Goedert,et al.  A Century of Alzheimer's Disease , 2006, Science.

[11]  L. Serrano,et al.  Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.

[12]  K. Sciarretta,et al.  Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues. , 2001, Biochemistry.

[13]  L. Tjernberg,et al.  Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands* , 1997, The Journal of Biological Chemistry.

[14]  P. Haris,et al.  The conformational analysis of peptides using fourier transform IR spectroscopy , 1995, Biopolymers.

[15]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[16]  Valeria Castelletto,et al.  Biological soft materials. , 2007, Angewandte Chemie.

[17]  M. Hurle,et al.  Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. , 1995, Biochemistry.

[18]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[19]  D. Gordon,et al.  Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Aβ1–40 fibrillogenesis , 2008 .

[20]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[21]  Lars Terenius,et al.  A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation* , 1999, The Journal of Biological Chemistry.

[22]  A. Barth,et al.  What vibrations tell about proteins , 2002, Quarterly Reviews of Biophysics.

[23]  Atanu Basu,et al.  Self-assembly of a dipeptide-containing conformationally restricted dehydrophenylalanine residue to form ordered nanotubes , 2007 .

[24]  M. Findeis,et al.  Modified-peptide inhibitors of amyloid beta-peptide polymerization. , 1999, Biochemistry.

[25]  P. Messersmith,et al.  Self‐Assembling Polymer–Peptide Conjugates: Nanostructural Tailoring , 2004 .